ANTX
AN2 Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.02
-0.01 (-0.20%)
Rating:C
Company Profile
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$5.01
Prev. Close
$5.03
Day Low
$4.92
Day High
$5.10
52W Low
$1.00
52W High
$6.91
Market Cap
$0.14B
Volume
0.02M